HIK (LSE) - Hikma Pharmaceuticals PLC

Exchange: London Exchange • Country: United Kingdom • Currency: GBX • Type: Common Stock • ISIN: GB00B0LCW083
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms in North America, the Middle East, North Africa, and Europe. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. The company was founded in 1978 and is headquartered in London, the United Kingdom. Web URL: https://www.hikma.com

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for HIK (LSE) - Hikma Pharmaceuticals PLC
  • Uncommon Growth Rate


Market Cap in USD 59m
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
GiC SubIndustry Pharmaceuticals
TER 0.00%
IPO / Inception


Fundamental 2.65
Dividend 7.39
Performance 5y 2.62
Rel. Performance vs Sector 2.16
Analysts -
Fair Price Total Ret. 19.30
Fair Price DCF todo


Growth TTM 79.34%
CAGR 5y 5.01%
CAGR / Mean Drawdown 5y 0.28
Sharpe Ratio TTM 2.79
Alpha vs SP500 TTM 68.99
Beta vs SP500 5y weekly 0.54
CAPM 6.53%
Average Daily Range 2m 1.90%
Reversal Oscillator 28.44
Volatility GJR Garch 1y 24.16%
Price / SMA 50 0.52%
Price / SMA 200 16.24%
Current Volume 229.2k
Average Volume 20d 821.9k


Yield TTM 2.96%
Yield on Cost 5y 3.77%
Dividends CAGR 5y 9.46%
Consistency of Dividends all time 96.1%